133 related articles for article (PubMed ID: 37899397)
1. A case of pancreatic cancer treated with chemotherapy combined with immunotherapy and targeted therapy.
Zhang B; Tang K; Dong X
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2023 Oct; 52(5):578-582. PubMed ID: 37899397
[TBL] [Abstract][Full Text] [Related]
2. A case of metastatic pancreatic adenocarcinoma with prolonged survival after combination of neoadjuvant FOLFIRINOX therapy and synchronous distal pancreatectomy and hepatectomy.
Neofytou K; Giakoustidis A; Smyth EC; Cunningham D; Mudan S
J Surg Oncol; 2015 May; 111(6):768-70. PubMed ID: 25556724
[TBL] [Abstract][Full Text] [Related]
3. [R0 Resection by Distal Pancreatectomy with En Bloc Celiac Axis Resection after Down-Staging by FOLFIRINOX Therapy in a Case of Pancreas Cancer--Report of a Case].
Makino H; Kametaka H; Fukada T; Seike K; Koyama T; Hasegawa A
Gan To Kagaku Ryoho; 2015 Nov; 42(12):1644-6. PubMed ID: 26805124
[TBL] [Abstract][Full Text] [Related]
4. Resection of pancreatic ductal adenocarcinoma with synchronous distant metastasis: is it worthwhile?
Buc E; Orry D; Antomarchi O; Gagnière J; Da Ines D; Pezet D
World J Surg Oncol; 2014 Nov; 12():347. PubMed ID: 25407113
[TBL] [Abstract][Full Text] [Related]
5. Nab-paclitaxel plus gemcitabine versus nab-paclitaxel plus gemcitabine followed by FOLFIRINOX induction chemotherapy in locally advanced pancreatic cancer (NEOLAP-AIO-PAK-0113): a multicentre, randomised, phase 2 trial.
Kunzmann V; Siveke JT; Algül H; Goekkurt E; Siegler G; Martens U; Waldschmidt D; Pelzer U; Fuchs M; Kullmann F; Boeck S; Ettrich TJ; Held S; Keller R; Klein I; Germer CT; Stein H; Friess H; Bahra M; Jakobs R; Hartlapp I; Heinemann V;
Lancet Gastroenterol Hepatol; 2021 Feb; 6(2):128-138. PubMed ID: 33338442
[TBL] [Abstract][Full Text] [Related]
6. Metastasized pancreatic carcinoma with neoadjuvant FOLFIRINOX therapy and R0 resection.
Schneitler S; Kröpil P; Riemer J; Antoch G; Knoefel WT; Häussinger D; Graf D
World J Gastroenterol; 2015 May; 21(20):6384-90. PubMed ID: 26034375
[TBL] [Abstract][Full Text] [Related]
7. Neoadjuvant modified-FOLFIRINOX followed by surgical resection of both the primary and metastatic tumors of a pancreatic hepatoid carcinoma with synchronous liver metastasis: A case report.
Ma T; Bai X; Li G; Wei S; Liang T
Medicine (Baltimore); 2017 Oct; 96(43):e8413. PubMed ID: 29069039
[TBL] [Abstract][Full Text] [Related]
8. Response and Survival Associated With First-line FOLFIRINOX vs Gemcitabine and nab-Paclitaxel Chemotherapy for Localized Pancreatic Ductal Adenocarcinoma.
Perri G; Prakash L; Qiao W; Varadhachary GR; Wolff R; Fogelman D; Overman M; Pant S; Javle M; Koay EJ; Herman J; Kim M; Ikoma N; Tzeng CW; Lee JE; Katz MHG
JAMA Surg; 2020 Sep; 155(9):832-839. PubMed ID: 32667641
[TBL] [Abstract][Full Text] [Related]
9. Pathologic complete response following FOLFIRINOX and olaparib treatment for hepatic metastasized pancreatic ductal adenocarcinoma with a germline BRCA mutation.
Okada K; Uemura K; Okamoto W; Sumiyoshi T; Shintakuya R; Otsuka H; Serikawa M; Ishii Y; Arihiro K; Takahashi S
Clin J Gastroenterol; 2023 Apr; 16(2):283-288. PubMed ID: 36574187
[TBL] [Abstract][Full Text] [Related]
10. Liver metastasis as an initial recurrence has no impact on the survival of patients with resectable pancreatic adenocarcinoma.
Tani M; Kawai M; Miyazawa M; Hirono S; Ina S; Nishioka R; Fujita Y; Uchiyama K; Yamaue H
Langenbecks Arch Surg; 2009 Mar; 394(2):249-53. PubMed ID: 18343944
[TBL] [Abstract][Full Text] [Related]
11. [A Case of Long-Term Survival of the Pancreatic Tail Cancer with the Concomitant Small Liver Metastasis].
Kase K; Okada R; Muto M; Watanabe J; Sato N; Kofunato Y; Ishigame T; Kimura T; Kenjo A; Shimura T; Marubashi S
Gan To Kagaku Ryoho; 2018 Feb; 45(2):387-389. PubMed ID: 29483456
[TBL] [Abstract][Full Text] [Related]
12. Case Report: Anlotinib combined with PD-1 inhibitor and sequential GA regimen or FOLFIRINOX Chemotherapy in treatment of KRAS G12V mutated pancreatic ductal adenocarcinoma with liver metastasis: A case and literature review.
Wang Y; Wang B; Xiang L; Deng J; Xu B; He P; Pu W; Wang H; Fan Y; Chen H
Front Immunol; 2022; 13():1016647. PubMed ID: 36311715
[TBL] [Abstract][Full Text] [Related]
13. Feasibility and Safety of Laparoscopic Radical Distal Pancreatosplenectomy with Adrenalectomy in Advanced Pancreatic Cancer.
Hong SS; Hwang HK; Lee WJ; Kang CM
Ann Surg Oncol; 2020 Dec; 27(13):5235-5236. PubMed ID: 32474822
[TBL] [Abstract][Full Text] [Related]
14. Conversion surgery for initially unresectable pancreatic ductal adenocarcinoma with synchronous liver metastasis after treatment with FOLFIRINOX.
Ozaki K; Hayashi H; Ikuta Y; Masuda T; Akaboshi S; Ogata K; Matumoto K; Ogawa K; Kamio T; Baba H; Takamori H
Clin J Gastroenterol; 2019 Dec; 12(6):603-608. PubMed ID: 30993652
[TBL] [Abstract][Full Text] [Related]
15. [Laparoscopic Liver Resection for Liver Metastasis from Unresectable Pancreatic Ductal Adenocarcinoma Well-Controlled by Chemotherapy-A Case Report].
Nobori C; Tsukamoto T; Nishiyama T; Kunimoto T; Kaizaki R; Inoue T; Nishiguchi Y
Gan To Kagaku Ryoho; 2020 Dec; 47(13):1881-1883. PubMed ID: 33468860
[TBL] [Abstract][Full Text] [Related]
16. [A Successful Case of Locally Advanced Pancreatic Cancer Undergoing Curative Total Pancreatectomy after Chemotherapy].
Terashima T; Kawamoto S; Maekawa K; Shinozaki N; Kuroki N
Gan To Kagaku Ryoho; 2020 Apr; 47(4):688-690. PubMed ID: 32389985
[TBL] [Abstract][Full Text] [Related]
17. Decreased serum carbohydrate antigen 19-9 levels after neoadjuvant therapy predict a better prognosis for patients with pancreatic adenocarcinoma: a multicenter case-control study of 240 patients.
Aoki S; Motoi F; Murakami Y; Sho M; Satoi S; Honda G; Uemura K; Okada KI; Matsumoto I; Nagai M; Yanagimoto H; Kurata M; Fukumoto T; Mizuma M; Yamaue H; Unno M;
BMC Cancer; 2019 Mar; 19(1):252. PubMed ID: 30898101
[TBL] [Abstract][Full Text] [Related]
18. CT evaluation after neoadjuvant FOLFIRINOX chemotherapy for borderline and locally advanced pancreatic adenocarcinoma.
Wagner M; Antunes C; Pietrasz D; Cassinotto C; Zappa M; Sa Cunha A; Lucidarme O; Bachet JB
Eur Radiol; 2017 Jul; 27(7):3104-3116. PubMed ID: 27896469
[TBL] [Abstract][Full Text] [Related]
19. [Resection of the remnant pancreas for recurrent pancreatic cancer after distal pancreatectomy-a case report].
Kinoshita S; Sho M; Akahori T; Nomi T; Yamato I; Hokutoh D; Yasuda S; Nakajima Y
Gan To Kagaku Ryoho; 2012 Nov; 39(12):1883-5. PubMed ID: 23267918
[TBL] [Abstract][Full Text] [Related]
20. Dramatic response of FOLFIRINOX regimen in a collision pancreatic adenocarcinoma patient with a germline BRCA2 mutation: a case report.
Shimmura H; Kuramochi H; Jibiki N; Katagiri S; Nishino T; Araida T
Jpn J Clin Oncol; 2019 Dec; 49(11):1049-1054. PubMed ID: 31612916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
